tradingkey.logo
搜尋

Progyny Inc

PGNY
添加自選
31.130USD
-0.360-1.14%
收盤 07-31 16:00美東報價延遲15分鐘
2.44B總市值
38.60本益比TTM

關於 Progyny Inc 公司

Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.

Progyny Inc簡介

公司代碼PGNY
公司名稱Progyny Inc
上市日期Oct 25, 2019
CEOAnevski (Peter)
員工數量675
證券類型Ordinary Share
年結日Oct 25
公司地址1359 Broadway
城市NEW YORK
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編10018
電話12128883124
網址https://www.progyny.com/
公司代碼PGNY
上市日期Oct 25, 2019
CEOAnevski (Peter)

Progyny Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Peter (Pete) Anevski
Mr. Peter (Pete) Anevski
Chief Executive Officer, Director
Chief Executive Officer, Director
617.11K
-0.87%
Mr. Jeffrey Gary (Jeff) Park
Mr. Jeffrey Gary (Jeff) Park
Lead Independent Director
Lead Independent Director
30.62K
+25.88%
Mr. Roger C. Holstein
Mr. Roger C. Holstein
Independent Director
Independent Director
20.70K
+32.81%
Ms. Allison Swartz
Ms. Allison Swartz
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
19.99K
-14.07%
Mr. Lloyd H. Dean
Mr. Lloyd H. Dean
Independent Director
Independent Director
18.49K
+36.73%
Ms. Cheryl M. Scott
Ms. Cheryl M. Scott
Independent Director
Independent Director
13.08K
--
Mr. Kevin K. Gordon
Mr. Kevin K. Gordon
Independent Director
Independent Director
11.27K
-10.95%
Mr. Geoffrey Clapp
Mr. Geoffrey Clapp
Chief Product Officer
Chief Product Officer
5.38K
-15.24%
Mr. David Schlanger
Mr. David Schlanger
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Dr. Norman C. Payson, M.D.
Dr. Norman C. Payson, M.D.
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Peter (Pete) Anevski
Mr. Peter (Pete) Anevski
Chief Executive Officer, Director
Chief Executive Officer, Director
617.11K
-0.87%
Mr. Jeffrey Gary (Jeff) Park
Mr. Jeffrey Gary (Jeff) Park
Lead Independent Director
Lead Independent Director
30.62K
+25.88%
Mr. Roger C. Holstein
Mr. Roger C. Holstein
Independent Director
Independent Director
20.70K
+32.81%
Ms. Allison Swartz
Ms. Allison Swartz
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
19.99K
-14.07%
Mr. Lloyd H. Dean
Mr. Lloyd H. Dean
Independent Director
Independent Director
18.49K
+36.73%
Ms. Cheryl M. Scott
Ms. Cheryl M. Scott
Independent Director
Independent Director
13.08K
--

常見問題

Progyny Inc的前五大股東是誰?

Progyny Inc的前五大股東如下:Mr. Peter (Pete) Anevski

有多少機構持有Progyny Inc(PGNY)的股份?

截至2026Q1,共有790家機構持有Progyny Inc的股份,合計持有的股份價值約為88.51M,占公司總股份的113.05% 。與2025Q4相比,機構持股有所增加,增幅為-31976779.00。

哪個業務部門對Progyny Inc的收入貢獻最大?

在2026Q1,Fertility benefits services revenue業務部門對Progyny Inc的收入貢獻最大,創收830.93M,占總收入的64.48% 。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有